• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 381023
Device Problem Packaging Problem (3007)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/18/2023
Event Type  malfunction  
Event Description
It was reported while using bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga the unit package was damaged.This occurred 100 times.There was no report of patient impact.The following information was provided by the initial reporter: packaging was broken, integrity of sterility of product breached.Refer picture attached.
 
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported while using bd insyte¿ autoguard¿ bc shielded iv catheter blood control technology 22ga the unit package was damaged.This occurred 100 times.There was no report of patient impact.The following information was provided by the initial reporter: packaging was broken, integrity of sterility of product breached.Refer picture attached.
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 25-jan-2023 h6: investigation summary: our quality engineer inspected the samples and photographs submitted for evaluation.The three photographs displayed similarities to that of the returned units.Through the visual inspection of the returned units, 39 of the returned units had sections of the bottom web that had been separated from the top web.The reported issue was confirmed.Further inspection revealed the bottom web had varying degrees of wrinkling including in the seal area.Sections where the seal was still intact had evidence of adhesive residue, although, the adhesive appeared more degraded when comparing to a representative unit.The imprint from the seal machine was present and consistent around the seal area.Finally, when looking at the bottom web against a light source, discoloration of the bottom web could be observed.Based on these observations, it is likely that the seal was adequately formed during packaging of the unit since there is evidence of the adhesive being present/activated and there is evidence that the heated press adequately pressed down on the entirety of the seal.Additionally, given the warping of the bottom web and its discoloration it is likely that the returned units were exposed to environmental factors, like humidity, that damaged the bottom web and degraded the seal.This type of damage may be caused postproduction during shipping or storage (at the customer site) due to inadequate storage/transportation conditions.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER BLOOD CONTROL TECHNOLOGY 22GA
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16331512
MDR Text Key309134863
Report Number1710034-2023-00086
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903810239
UDI-Public(01)00382903810239
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K201075
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number381023
Device Lot Number2179504
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/27/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-